Prevalence of Oral Manifestations and Associated Factors in the HIV Infection at a Reference Hospital from the Health's Unified System, Brazil
DOI:
https://doi.org/10.12970/2309-0529.2013.01.02.3Keywords:
Oral manifestations, mouth disease, AIDS-related opportunistic infections, HIV.Abstract
The severe control by the Brazilian Ministry of Health on the HIV infection suggests that all the opportunistic infections related to this disease are in a low frequency. This study aimed to characterize the oral lesions profile in patients with HIV/AIDS who presented to the public health system in Goiania, Brazil. An oral clinical examination was developed and was based on the EC-Clearinghouse on oral problems related to HIV infection. A questionnaire was completed, medical data were collected and photos were taken. A total of 201 patients were divided into two groups: Group I (92 HIV-positive patients with CD4+ count above 200 cells/mm3 and absence of symptoms of AIDS) and Group II (109 HIV-positive patients with CD4+ count below 200 cells/mm3 and with signs and symptoms of AIDS). The total prevalence for oral manifestations ranged from 19.60% (Group I) to 33.00% (Group II). Periodontitis associated with HIV infection occurred in 5.43% (Group I) and 11.00% (Group II) of patients. Linear gingival erythema occurred in 4.34% (Group I) and 7.34% (Group II) of patients. Erythematous candidiasis affected 4.34% (Group I) and 2.75% (Group II) of patients. Pseudomembranous candidiasis affected 1.83% of Group I patients. A significant association was observed between the occurrence of oral lesions related to HIV infection and age (p<0.05; OR 2.82; 95% CI (1.31-6.05)) and between HIV-related oral lesions and prosthesis wearing (p<0.05; OR 3.6; 95% CI (1.2-11.4)) in Group I patients. In Group II patients, an association was observed between the presence of caries and HIV-related oral lesions (p<0.005; OR 2.4; 95% CI (1.1-5.4)). Dry mouth was the most observed complaint related to antiretroviral therapy (7.80% in Group I and 11.00% in Group II). In conclusion, the Group II presented the highest frequency of lesions, and periodontitis was the most prevalent oral lesion. Age and prosthesis wearing were factors associated with the development of these lesions among Group I patients, while the presence of dental caries was associated with oral lesions in Group II patients.References
[1] Ranganathan K, Hemalatha R. Oral lesions in HIV infection in developing countries: an overview. Adv Dent Res 2006; 19: 63-8. http://dx.doi.org/10.1177/154407370601900113
[2] Chidzonga MM. HIV/AIDS orofacial lesions in 156 Zimbabwean patients at referral oral and maxillofacial surgical clinics. Oral Dis 2003; 9: 317-22. http://dx.doi.org/10.1034/j.1601-0825.2003.00962.x
[3] Urízar JMA, Goicouría MAE, Del Valle AE. Síndrome de Imunodeficiência Adquirida: Manifestaciones en la cavidad bucal. Med Oral Patol Oral Cir Bucal 2004; 9: 148-57.
[4] Agbelusi GA, Wright AA. Oral lesion as indicators of HIV infection among routine in Lagos, Nigeria. Oral Dis 2005; 11: 370-3. http://dx.doi.org/10.1111/j.1601-0825.2005.01132.x
[5] Tamí-Maury I, Coulibaly YI, Cissoko SS, Dao S, Kristensen S. First report of HIV- related oral manifestations in Mali. Pan Afr Med J 2012; 11: 18.
[6] Cherry-Peppers G, Daniel CO, Meeks V, Sanders CF, Reznik D. Oral Manifestations in The Era of HAART. J Natl Med Assoc 2003; 95(Suppl 2): 21S-32S.
[7] Aleixo RQ, Scherma AP, Guimarães G, Cortelli JR, Cortelli SC. DMFT index and oral mucosal lesions associated with HIV infection: cross sectional study in Porto Velho, Amazonian Region - Brazil. Braz J Infect Dis 2010; 14: 449- 56.
[8] EC- Clearinghouse on oral problems related to HIV infection and WHO Collaborating Centre on oral manifestations of the immunodeficiency virus. Classification and diagnostic criteria for oral lesions in HIV infection. J Oral Pathol Med 1993; 22: 289-91. http://dx.doi.org/10.1111/j.1600-0714.1993.tb01074.x
[9] Agwu E, Ihongbe JC, Tirwomwe JF, Pazos V, Tirwomwe M, Casadesus L. Appraisal of oral lesions status of HIV/AIDS patients in south western Uganda. Braz J Oral Sci 2008; 7: 1591-5.
[10] Gasparin AB, Ferreira FV, Danesi CC, et al. Prevalência e fatores associados às manifestações bucais em pacientes HIV positivos atendidos em cidade sul-brasileira. Cad Saude Pública 2009; 25: 1307-15. http://dx.doi.org/10.1590/S0102-311X2009000600013
[11] Khongkunthian P, Grote M, Isaranatan W, Plyaworawong S, Reichart PA. Oral manifestations in HIV-positive adults from northern Thailand. J Oral Pathol Med 2001; 30: 220-3. http://dx.doi.org/10.1034/j.1600-0714.2001.300405.x
[12] Bendick C, Schelfele C, Reichart PA. Oral manifestations in 102 cambodian patients with HIV infection and AIDS. J Oral Pathol Med 2002; 31: 1-4. http://dx.doi.org/10.1034/j.1600-0714.2002.310101.x
[13] Kerdpon D, Pongsiriwet S, Pangsomboon K, et al. Oral manifestations of HIV infection in relation to clinical CD4 immunological status in northern and southern Thai patients. Oral Dis 2004; 10: 138-44. http://dx.doi.org/10.1046/j.1601-0825.2003.00990.x
[14] Amorim JA, Souza FMB, Costa EB, Carneiro VSM, De Lucena AAG. Prevalência das doenças estomatológicas em pacientes HIV positivos. Odont Clín – Científ 2009; 8: 127- 31.
[15] Vajpayee M, Kanswal P, Seth P, Wiq N. Spectrum of opportunistic infections and profile of CD4 + Counts among AIDS Patients in North India. Infection 2003; 31: 336-40.
[16] Nobre V, Braga E, Rayes A, et al. Opportunistic infections in patients with AIDS admitted to an university hospital of the southeast of Brazil. Rev Inst Med Trop São Paulo 2003; 45: 69 -4. http://dx.doi.org/10.1590/S0036-46652003000200003
[17] Jensen TO, Tam VV, Mai NT, et al. Oral and constitutional manifestations of HIV-infected hospital patients in northern Vietnam. Southeast Asian J Trop Med Public Health 2005; 36: 1459-68.
[18] Sharma G, Pai KM, Suhas S, Ramapuram JT, Doshi D, Anup N. Oral manifestations in HIV/AIDS infected patients from India. Oral Dis 2006; 12: 537-42. http://dx.doi.org/10.1111/j.1601-0825.2006.01232.x
[19] Jané-Salas E, Chimenos-Kustner E, López-López J, RosellóLlabrés X, Ocaña-Rivera I. Efecto de los tratamentos antirretrovirales en las manifestaciones orales de los pacientes VIH+ . Avances en odontoestomatol 2006; 22: 315- 26. http://dx.doi.org/10.4321/S0213-12852006000600003
[20] Carpio E, López V, Fardales V, Benítez I. Oral manifestations of HIV infection in adults patients from province of Sancti Spiritus, Cuba. J Oral Pathol Med 2009; 38: 126-31. http://dx.doi.org/10.1111/j.1600-0714.2008.00716.x
[21] Medeiros CF, Santos TB, Albuquerque Júnior RLC, Moura SAB. Relação entre as manifestações estomatológicas, contagem de células CD4 + e carga viral em pacientes HIV positivos. Pesq Bras Odontoped Clín Integr 2007; 7: 271-6. http://dx.doi.org/10.4034/1519.0501.2007.0073.0013
[22] Pinheiro A, Marcenes W, Zakrzewska JM, Robinson PG. Dental and oral lesions in HIV infected patients: a study in Brazil. Int Dent J 2004; 54: 131-7. http://dx.doi.org/10.1111/j.1875-595X.2004.tb00268.x
[23] Ranganathan K, Magesh KT, Kumarasamy N, Solomon S, Viswanathan R, Johnson NW. Greater severity and extent ofperiodontal breakdown in 136 south indian human immunodeficiency virus seropositive patients than in normal controls: A comparative study using community periodontal index of treatment needs. Indian J Dent Res 2007; 18: 55-9. http://dx.doi.org/10.4103/0970-9290.32420
[24] Mattos SL, Santos VR, Ferreira EF. Prevalência de lesões de mucosa bucal em pacientes HIV positivos da unidade de referência especializada em doenças infecciosas e parasitárias especiais – URE- DIPE (Belém-Pará). URL: http://www.patologiaoral.com.br/texto46.asp (accessed November 18, 2012).
[25] Ortega KL, Vale DA, Magalhães MHCG. Impact of PI and NNRTI HAART – based therapy on oral lesions of brazilian HIV-infected patients. J Oral Pathol Med 2009; 38: 489-94. http://dx.doi.org/10.1111/j.1600-0714.2009.00783.x
[26] Aleva NA, Birman EG, Afonso Jr. W, et al. Erythematous candidosis in patients with complete dentures and HIV/AIDS. Mycoses 2007; 50: 407-11. http://dx.doi.org/10.1111/j.1439-0507.2007.01390.x
[27] Miziara ID, Lima AS, De La Cortina RAC. Candidíase oral e leucoplasia pilosa como marcadores de progressão da infecção pelo HIV em pacientes brasileiros. Rev Bras Otorrinolaringol 2004; 70: 310-4. http://dx.doi.org/10.1590/S0034-72992004000300005
[28] Adedigba MA, Ogunbodede EO, Jeboda SO, Naidoo S. Patterns of oral manifestation of HIV/AIDS among 225 Nigerian patients. Oral Dis 2008; 14: 341-6. http://dx.doi.org/10.1111/j.1601-0825.2007.01384.x
[29] Schmidt-Westhausen AM, Priepke F, Bergmann FJ, Reichart PA. Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy. J Oral Pathol Med 2000; 29: 336-41. http://dx.doi.org/10.1034/j.1600-0714.2000.290708.x
[30] Adurogbangba MI, Aderinokum GA, Odaibo GN, Olaleye OD, Lawoyin TO. Orofacial lesions and CD4 counts associated with HIV/AIDS in an adult population in Oio State, Nigeria. Oral Dis 2004; 10: 319-26. http://dx.doi.org/10.1111/j.1601-0825.2004.01036.x
